Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia-Reference-Cited by-同舟云学术

Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia

Published:2023-01-01 Issue:1 Volume:30 Page:100-104
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Tanaka Katsunao¹,Koseki Masahiro¹,Kato Hisashi²,Miyashita Kazuya³,Okada Takeshi¹,Kanno Kotaro¹,Saga Ayami¹,Chang Jiuyang¹,Omatsu Takashi¹,Inui Hiroyasu¹,Ohama Tohru¹,Nishida Makoto⁴,Yamashita Shizuya⁵,Sakata Yasushi¹

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

2. Department of Hematology and Oncology, Osaka University Graduate School of Medicine

3. Immuno-Biological Laboratories (IBL) Co., Ltd., Fujioka

4. Health Care Division, Health and Counseling Center, Osaka University

5. Rinku General Medical Center

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/30/1/30_63348/_pdf

Reference15 articles.

1. 1) Okazaki H, Gotoda T, Ogura M, Ishibashi S, Inagaki K, Daida H, Hayashi T, Hori M, Masuda D, Matsuki K, Yokoyama S and Harada-Shiba M: Current Diagnosis and Management of Primary Chylomicronemia. J Atheroscler Thromb, 2021; 28: 883-904

2. 2) Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N, Research Committee for Primary Hyperlipidemia RoMaIDbtMoHL and Welfare in J: Diagnosis and management of type I and type V hyperlipoproteinemia. J Atheroscler Thromb, 2012; 19: 1-12

3. 3) Kihara S, Matsuzawa Y, Kubo M, Nozaki S, Funahashi T, Yamashita S, Sho N and Tarui S: Autoimmune hyperchylomicronemia. N Engl J Med, 1989; 320: 1255-1259

4. 4) Miyashita K, Fukamachi I, Machida T, Nakajima K, Young SG, Murakami M, Beigneux AP and Nakajima K: An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome. Clin Chim Acta, 2018; 487: 174-178

5. 5) Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charriere S, Fong LG, Nakajima K and Young SG: Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia. N Engl J Med, 2017; 376: 1647-1658

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation analysis of hypertension, traditional Chinese medicine constitution, and LPL gene polymorphism in the elderly in communities in Shanghai;Technology and Health Care;2024-01-05

2. The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia;Biomedicine & Pharmacotherapy;2023-12

3. Eltrombopag/prednisolone;Reactions Weekly;2023-06-17

4. A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease;Journal of Clinical Lipidology;2023-01